Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terazosin Therapy in Pre-Motor and Symptomatic Parkinson's Disease
NCT05109364Phase 2Active, not recruiting
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Sep 2022
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terazosin in Parkinson's disease (PD), REM sleep behavior disorder (RBD), sponsored by Cedars-Sinai Medical Center. Started Sep 2022; status: active, not recruiting.
02
Drugs
terazosin
03
Conditions
Parkinson's disease (PD)REM sleep behavior disorder (RBD)
Beyond the preview
Go deeper on NCT05109364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05109364.